Responsibility & Innovation
In every facet of our operations, we use creative solutions. We keep developing new methods, making medications that are more and more user-friendly, and improving the efficiency and environmental safety of the manufacturing processes. In order to promote our products, manage our sales, and develop relationships with patients and the medical community, we employ cutting-edge ideas.
We want to make it possible for medical professionals to provide patients with the best treatment possible. To assist patients live a long and healthy life, we want to develop comprehensive health solutions.
Accountability for the Products
As members of the pharmaceutical sector, we acknowledge our duty to protect human life and health. We place a high priority on patient safety as well as the quality of our products because of this.
-
At every stage of product development, creation, storage, distribution, and sale, we pay attention to quality.
-
The strictest Good Manufacturing Practice guidelines are followed when producing our products (GMP).
-
For all manufactured medications and substances, the Main Pharmaceutical Inspectorate has granted GMP certificates.
-
To assure the safety of our products, personnel, and the environment, we apply the most recent technologies.
Ethical Marketing
We provide clear, accurate information that has been independently verified. We keep an eye on the caliber of our marketing activities, and we accept responsibility for continuously improving the standards in this area. We make sure to convey accurate and understandable information regarding our goods and their effects.
We make sure that patients use the patient leaflet appropriately and safely by checking that its contents align with the findings of "clarity tests," or consultations with the intended user groups of the medical product. The information in the leaflet needs to be accessible to the patient, understood by them, and dealt with appropriately.
Products Packaging
A new prescription medicine packaging method that intends to improve readability of packaging, reduce the risks of drug dispensing, and increase patient safety was put into place in 2022 in collaboration with pharmacists. Interviews with patients and pharmacists, who were consulted at every stage of the process, served as the basis for the innovative prescription drug package that Medinovis is offering. The modification is also a part of a strategic strategy of Medinovis brand unification that the corporation started to strengthen its global portfolio.
The new packaging's primary goal is to increase functionality. The design takes into account the particular of pharmacists' work as well as the needs of elderly and visually impaired patients. It also considers how the packaging is organized on pharmacy shelves and in drawers.
​
Our packaging design has five elements that reduce the possibility of medicine dispensing mistakes in pharmacies and increase convenience.
For pharmacists:
-
Error risk is reduced by dosage color-coding.
-
It is simpler to distinguish between medicine names and dosage information when they are printed in large type.
-
Since pharmacy drawer space is limited, the drug name and dosage information are printed on three sides of the packaging, making them visible regardless of how the packaging are placed (horizontally, vertically or flat on the shelf).
-
A drug use table provides room for the pharmacist or patient to record the proper dosage times for various medications.
-
To make it simpler to list the medications at the pharmacy, specific therapeutic categories are given different colors.
​
For Patients Safety:
-
For the benefit of the elderly and visually handicapped, medicine names and dose information are color-coded and printed in a legible font.
-
In order to increase patient compliance, a drug use table (on the back) provides room to note when the drug should be taken.
-
Finding the medication in the home medicine cabinet is made simpler by the presence of essential information (name, dose, and content) on three sides of the box.
The Packaging's Window For Communications
We make sure that the packaging for our products ensures both patient and pharmacist access and ensures that the medication is utilized safely. For this reason, we added a particular communication window to the packaging system for prescription medications.
Two fields make up the window. The first is a set area at the rear of the packet where the pharmacy price label will go. The patient-important information, such as the medication's composition, dosage, or supplementary cautions, are not obscured by this solution.
Patients can remember how to take the medication more easily thanks to the second field. This is due to the possibility that they could misplace the unique information their doctor gave them. Within the lines relating to the time of day, the patient may note the drug dose regimen. This has a considerable impact on maintaining a regular medication schedule and the effectiveness of the treatment.
Pharmacovigilance
We maintain ongoing pharmacovigilance to reduce any hazards associated with using our products. In all markets where our goods are utilized, a specialized company department gathers, examines, and archives notifications of negative effects. We consider the causes, assess the risk/benefit ratio of using a medicine, and put risk reduction strategies into action.
There are four minimal requirements for a report to be deemed genuine in order to unify and give adverse reaction reports as comprehensive as possible:
-
A CLIENT WHO CAN BE IDENTIFIED (by name, gender, age, or range of ages),
-
POSSIBLE DRUGS;
-
A POSITIVE REACTION;
-
A Reporter (name and contacts of the consumer, family member, or health professional).
Prior to going on sale, medicines and health goods undergo considerable research and testing. However, not every circumstance to which the drugs and healthcare items would be subjected after they are commercialized can be foreseen. As a result, exceptional circumstances must also be recorded and reported in addition to the idea of an unpleasant reaction, even if they are unrelated to one. Please take into account the following unique circumstances:
-
Exposure during pregnancy
-
Exposure during breastfeeding
-
Inadvertent or accidental exposure
-
Medication errors
-
Abuse
-
Lack of drug effect
-
Suspected transmission of infectious agents
-
Occupational exposure
-
Off-label use
If you are unable to meet the four requirements, you should nonetheless submit the information you have. Pharmacovigilance is heavily regulated and required for businesses falling under our purview. However, expanding knowledge about marketed goods is essential to ensuring their safety, efficacy, and quality. This requires cooperation from all parties involved in the health process, including health professionals, consumers, the pharmaceutical business, and regulators. Visit the "Contacts" link and complete the contact form if you'd like to report a negative reaction.